Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales49 41448 51849 10952 10053 58455 567
EBITDA15 26014 31114 70516 42217 55518 742
Operating profit (EBIT)13 79012 98712 85012 76713 41414 309
Pre-Tax Profit (EBT)8 1347 8178 99911 28711 42312 855
Net income17 7836 7127 7039 3039 24810 450
P/E ratio11,925,925,816,219,417,3
EPS ( $ )7,292,803,284,874,064,55
Dividend per Share ( $ )2,652,702,802,953,053,18
Yield3,06%3,72%3,31%3,73%3,87%4,03%
Reference price ( $ )86.5972.6384.5578.928478.928478.9284
Announcement Date01/27/2016
11:15am
01/25/2017
11:25am
01/24/2018
06:23am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt16 48416 02519 04713 41511 1777 970
Finance------
Operating income (EBITDA)15 26014 31114 70516 42217 55518 742
Leverage
(Debt/EBITDA)
1,08x1,12x1,30x0,82x0,64x0,43x
Capital Expenditure2 3671 8621 6962 5671 9351 974
Book Value Per Share (BVPS)32,5 $31,5 $32,0 $33,6 $34,3 $35,2 $
Cash Flow per Share4,88 $4,78 $5,38 $5,90 $6,16 $6,92 $
Announcement Date01/27/2016
11:15am
01/25/2017
11:25am
01/24/2018
06:23am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 201 464 M$ -
Entreprise Value (EV) 214 880 M$ 212 641 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 16,2x 19,4x
Capitalization / Revenue 3,87x 3,76x
EV / Revenue 4,12x 3,97x
EV / EBITDA 13,1x 12,1x
Yield (DPS / Price) 3,73% 3,87%
Price to book (Price / BVPS) 2,35x 2,30x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 24,5% 25,0%
operating Leverage (Delta EBIT / Delta Sales) - 1,78x
Net Margin (Net Profit / Revenue) 17,9% 17,3%
ROA (Net Profit / Asset) 7,49% 8,06%
ROE (Net Profit / Equities) 14,6% 15,1%
Rate of Dividend 60,5% 75,2%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   4,93% 3,61%
Cash Flow / Sales 25,5% 25,9%
Capital Intensity (Assets / Sales) 2,38x 2,14x
Financial Leverage (Net Debt / EBITDA) 0,82x 0,64x
EPS & Dividend